Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Alcohol injection offers new hope for chronic back pain sufferers

NCT ID NCT07151027

Symptom relief Sponsor: Fayoum University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether adding alcohol to a standard numbing and steroid injection could provide better pain relief for people with sacroiliac joint pain. Fifty-four adults with chronic low back pain from the sacroiliac joint received an ultrasound-guided injection, with or without alcohol. The main goal was to measure pain reduction using a standard pain scale, and the study also looked at improvements in daily function.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

54 people

The number who actually took part.

Started

Aug 2025

Finished

Feb 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Adult patients of either gender diagnosed with sacroiliac joint pain. 2. Patient aged 18-60 years old. 3. Patients with American Society of Anesthesiologists (ASA) physical status I-II. 4. Chronic pain at sacroiliac joint for more than 12 weeks. Exclusion Criteria: 1. Patients with MRI confirmed other cause of Low back pain as (disc prolapse, spinal canal stenosis, etc.). 2. Patients without any positive provocative tests (FABER, Gaenslen's and Fortin's finger tests). 3. Patients had findings suggestive of another source of axial back pain. 4. Patients with symptoms radiating past the knee. 5. Patients with less than 5/5 strength in the lower extremity. 6. Patients with diminished reflexes. 7. Patients diagnosed with myelopathy, and positive neural tension signs including straight leg raise and/or slump test. 8. Obese patients (BMI ≥ 35 kg/m²). 9. Infection at the injection site. 10. Patients who have undergone previous spine or pelvic surgery. 11. Coagulation disorders as bleeding tendency and platelet dysfunction. 12. Allergy to local anesthetics. 13. Patients with mental disorders, as well as drug abuse. 14. Lumbar facet steroid injections within the past 12 months

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Alcohol induced neurolysis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

agnosia Low Back Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Alcohol induced neurolysis Low back pain Sacro iliac joint pain

Contacts and locations

Locations

  • FayoumU

    Al Fayyum, Faiyum Governorate, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.